Clinical Trials Logo

Vaginitis clinical trials

View clinical trials related to Vaginitis.

Filter by:

NCT ID: NCT03032848 Completed - Clinical trials for Pelvic Organ Prolapse

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

Start date: November 26, 2013
Phase: Phase 4
Study type: Interventional

To evaluate the difference of three vaginal estrogens creams comparative with placebo on improvement of hormonal cytology, local and systemic climacteric complaints, as well as its endometrial security.

NCT ID: NCT02995694 Completed - Atrophic Vaginitis Clinical Trials

A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis

Start date: March 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the therapeutic equivalence of Alvogen's estradiol vaginal cream to Estrace® cream and superiority of both products to placebo. The protocol describes a randomized, double-blind, multi-dose, placebo-controlled, parallel study of a 7 day treatment.

NCT ID: NCT02888197 Completed - Mycoses Clinical Trials

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Start date: August 16, 2016
Phase: N/A
Study type: Observational

Non-interventional extension study to investigate VVC recurrence and candida colonization following the P2 acute VVC study

NCT ID: NCT02869165 Completed - Menopause Clinical Trials

Vaginal and Urinary Microbiome Trial

Start date: January 2017
Phase: Phase 4
Study type: Interventional

A randomized controlled trial looking at the effects of vaginal estrogen and a nonhormonal alternative on the vaginal and urinary microbiome in women with genitourinary syndrome of menopause.

NCT ID: NCT02866227 Completed - Bacterial Vaginosis Clinical Trials

TOL-463 Phase 2 Study for Vaginitis

Start date: July 15, 2016
Phase: Phase 2
Study type: Interventional

This is a Phase II study designed to assess the safety and efficacy of an investigational product, TOL-463, to treat vaginitis.

NCT ID: NCT02763696 Recruiting - Vaginitis Clinical Trials

Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota

ESSACWVM
Start date: May 10, 2016
Phase: N/A
Study type: Observational [Patient Registry]

The vaginal microbiota is an important biological barrier for host against pathogens or opportunistic pathogens. Undermining the balance of the vagina is closely related to infectious diseases and tumors. The vaginal microbiota of child-bearing women of age is dominated by Lactobacillus species, including major four species: Lactobacillus crispatus, Lactobacillus jensenii, Lactobacillus gasseri and Lactobacillus iners, followed by obligate anaerobes such as Gardnerella vaginalis, Atopobium vaginae, Mobiluncus curtisii, and Prevotella . Currently, There are almost 99% bacteria can not to be found with bacterial culture. Based on microscopy and conventional culture method to obtain vaginal microflora information have a variety of deviation. For this reason, The in-depth study of complex vaginal flora and the correct understanding of disease faces a serious obstacle. With the development of High-throughput sequencing technology, metagenomics can get all the composition and distribution of microorganisms from the sample which traditional knowledge may not be with microorganism culture method. Therefore, Re-evaluation of existing microflora diagnostic criteria for clinical diagnosis of the disease is necessary. In this study, the investigators use high-throughput sequencing technology to detect women of childbearing age vaginal microflora of metagenomic distribution. Including bacteria, fungi, viruses, protozoa, and other microorganisms. Based on the study results of metagenomic, the investigators want to re-cognition the"normal flora"of women of childbearing age ,and develop vaginal microflora microscopic evaluation of the integrity of the reference standard.

NCT ID: NCT02733731 Recruiting - Atrophic Vaginitis Clinical Trials

The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis

Start date: February 2016
Phase: Phase 1
Study type: Interventional

Objective:To evaluate the effect and safety of the traditional chinese medicine oil agent on senile atrophic compared as compared to estriol cream in aged woman. Design: A randomized double-blind controlled trial. Setting: The hospital ward. Participants: 200 postmenopausal woman with senile vaginitis (mean age 56). Intervention: The traditional chinese medicine oil and estriol cream were separately intravaginal administrated in treatment group and control group for 3 weeks,follow-up 1 month. Measurement: symptom improving(pain and itch) and onset time, edema-size of vaginal wall, vaginal discharge, and PH changes.

NCT ID: NCT02733432 Completed - Mycoses Clinical Trials

RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Start date: June 8, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if two topical formulations of CD101 are safe and effective in the treatment of acute moderate to severe vulvovaginal candidiasis (VVC) compared to oral fluconazole.

NCT ID: NCT02691936 Completed - Menopause Clinical Trials

Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy

VeLVET
Start date: March 2016
Phase: N/A
Study type: Interventional

This is a multi-centered, randomized prospective single blinded clinical trial comparing CO2 fractionated vaginal laser therapy and vaginal estrogen cream therapy in the treatment of vulvovaginal atrophy/GSM.

NCT ID: NCT02641717 Completed - Candidiasis Clinical Trials

Validity of Patient-Collected Wet Mounts

Start date: November 2015
Phase: N/A
Study type: Interventional

Purpose/Objectives: To compare wet mount findings for clue cells, yeast, trichomonads and white blood cells per high-power field in self-collected vaginal specimens, compared to clinician-collected specimens, among symptomatic women visiting the San Antonio Metropolitan Health sexually transmitted disease clinic. Research Design/Plan: Prospective, non-randomized, non-blinded trial Methods: Obtain informed consent and specimens from 40 symptomatic adult females (eg abnormal discharge, odor and/or itching). Calculate concordance between clinician- and patient-collected samples using a Wilcoxon Matched-Pair test. Calculate sensitivity, specificity, positive predictive value and negative predictive value of the patient-collected wet mount, using the clinician-collected specimens as the "gold standard." Clinical Relevance: A "wet mount," or microscopic examination, is commonly used to diagnose trichomoniasis and yeast in females, and constitutes one diagnostic element for bacterial vaginosis. While patient-collected vaginal swabs are acceptable for nucleic acid probe tests for chlamydia and gonorrhea and nucleic acid probe tests for trichomoniasis little information about patient-collected wet mounts exists in the literature. Self-collection by women before being seen by a clinician can increase the speed and efficiency of the visit. The method is highly acceptable to women. In the investigators' clinic, women routinely collect their own gonorrhea and chlamydia swabs, so adding an additional swab would not be burdensome.